Laurus Labs Ltd (LAURUSLABS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1002699,
    "name": "Laurus Labs",
    "stock_name": "Laurus Labs",
    "full_name": "Laurus Labs Ltd",
    "name_url": "stocks-analysis/laurus-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,009.25",
    "chg": 8.25,
    "chgp": "0.82%",
    "dir": 1,
    "prev_price": "1,001.00",
    "mcapval": "54,741.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 540222,
    "symbol": "LAURUSLABS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE947Q01028",
    "curr_date": "Dec 17",
    "curr_time": "",
    "bse_nse_vol": "13.12 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 17, 2025",
    "traded_date_str": "2025 12 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/laurus-labs-1002699-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Laurus Labs Sees Revision in Market Evaluation Amid Strong Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/laurus-labs-downgraded-to-buy-by-marketsmojo-amid-valuation-concerns-3761151",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/LaurusLabs_mojoScore_3761151.png",
        "date": "2025-12-17 10:10:20",
        "description": "Laurus Labs, a midcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting recent shifts in its fundamental and technical outlook. Despite this adjustment, the company continues to demonstrate robust financial performance and market resilience."
      },
      {
        "title": "Laurus Labs Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/laurus-labs-technical-momentum-shifts-amid-mixed-indicator-signals-3760766",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/LaurusLabs_technicaldot_3760766.png",
        "date": "2025-12-17 08:14:14",
        "description": "Laurus Labs, a key player in the Pharmaceuticals & Biotechnology sector, is exhibiting a nuanced shift in its technical momentum as recent evaluation adjustments reflect a transition from a bullish to a mildly bullish trend. This development comes amid a complex interplay of technical indicators, including MACD, RSI, moving averages, and others, which collectively paint a detailed picture of the stock’s current market stance."
      },
      {
        "title": "Laurus Labs Hits New 52-Week High of Rs.1040, Marking Significant Milestone",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/laurus-labs-hits-new-52-week-high-of-rs1040-on-1-dec-2025-3738551",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/LaurusLabs_priceRelatedfactors_3738551.png",
        "date": "2025-12-01 11:27:13",
        "description": "Laurus Labs, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.1040 today, underscoring a notable phase of momentum in its stock performance. This milestone reflects the company’s sustained upward trajectory amid a broadly positive market environment."
      },
      {
        "title": "Laurus Labs Hits New 52-Week High of Rs.1040 Marking Significant Milestone",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/laurus-labs-hits-new-52-week-high-of-rs1040-on-1-dec-2025-3738550",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/LaurusLabs_priceRelatedfactors_3738550.png",
        "date": "2025-12-01 11:27:12",
        "description": "Laurus Labs, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high today, touching Rs.1040. This milestone reflects the stock’s sustained momentum and strong performance over the past year, significantly outpacing broader market indices."
      },
      {
        "title": "Laurus Labs Hits New 52-Week High of Rs.1040 Marking Significant Milestone",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/laurus-labs-hits-new-52-week-high-of-rs1040-on-1-dec-2025-3738547",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/LaurusLabs_priceRelatedfactors_3738547.png",
        "date": "2025-12-01 11:27:09",
        "description": "Laurus Labs has reached a new 52-week high, touching Rs.1040 today, underscoring a notable milestone in its market performance within the Pharmaceuticals & Biotechnology sector. This achievement reflects sustained momentum supported by strong financial metrics and positive quarterly results."
      },
      {
        "title": "Laurus Labs Hits New 52-Week High of Rs.1040 Marking Strong Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/laurus-labs-hits-new-52-week-high-of-rs1040-on-1-dec-2025-3738549",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/LaurusLabs_priceRelatedfactors_3738549.png",
        "date": "2025-12-01 11:27:09",
        "description": "Laurus Labs, a prominent player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.1040 today, underscoring a significant milestone in its market performance. This achievement reflects sustained momentum supported by robust financial metrics and favourable market conditions."
      },
      {
        "title": "Laurus Labs Stock Hits All-Time High at Rs.1036 Amid Strong Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/laurus-labs-stock-hits-all-time-high-of-rs1036-on-1-dec-2025-3737750",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/LaurusLabs_priceRelatedfactors_3737750.png",
        "date": "2025-12-01 09:33:06",
        "description": "Laurus Labs has reached a significant milestone by hitting a new 52-week high of Rs.1036, marking an all-time peak for the pharmaceutical and biotechnology company. This achievement reflects a sustained period of robust performance across multiple financial metrics and market indicators."
      },
      {
        "title": "Laurus Labs Sees Notable Surge in Open Interest Amid Rising Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/laurus-labs-sees-sharp-open-interest-surge-signalling-bullish-market-positioning-3733835",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LaurusLabs_oi_spurts_by_underlying_3733835.png",
        "date": "2025-11-27 15:00:17",
        "description": "Laurus Labs, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a significant rise in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning. This development coincides with the stock trading near its 52-week high and outpacing sector performance, reflecting a dynamic phase for the company’s shares."
      },
      {
        "title": "Laurus Labs Sees Notable Surge in Open Interest Amid Rising Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/laurus-labs-sees-sharp-open-interest-surge-signalling-bullish-market-positioning-3733764",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LaurusLabs_oi_spurts_by_underlying_3733764.png",
        "date": "2025-11-27 14:00:18",
        "description": "Laurus Labs, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning. This development coincides with the stock trading near its 52-week high and outpacing sector performance, reflecting growing investor focus on the company’s prospects."
      }
    ],
    "total": 623,
    "sid": "1002699",
    "stock_news_url": "https://www.marketsmojo.com/news/laurus-labs-1002699"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "12-Dec-2025",
      "details": "Please see annexed enclosure",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "02-Dec-2025",
      "details": "Please see annexed enclosure",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "19-Nov-2025",
      "details": "Please see annexed enclosure",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Laurus Labs Ltd has declared <strong>40%</strong> dividend, ex-date: 31 Oct 25",
          "dt": "2025-10-31",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Laurus Labs Ltd has announced <strong>2:10</strong> stock split, ex-date: 29 Sep 20",
          "dt": "2020-09-29",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Laurus Labs Sees Revision in Market Evaluation Amid Strong Financials

2025-12-17 10:10:20

Laurus Labs, a midcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting recent shifts in its fundamental and technical outlook. Despite this adjustment, the company continues to demonstrate robust financial performance and market resilience.

Laurus Labs Technical Momentum Shifts Amid Mixed Indicator Signals

2025-12-17 08:14:14

Laurus Labs, a key player in the Pharmaceuticals & Biotechnology sector, is exhibiting a nuanced shift in its technical momentum as recent evaluation adjustments reflect a transition from a bullish to a mildly bullish trend. This development comes amid a complex interplay of technical indicators, including MACD, RSI, moving averages, and others, which collectively paint a detailed picture of the stock’s current market stance.

Laurus Labs Hits New 52-Week High of Rs.1040, Marking Significant Milestone

2025-12-01 11:27:13

Laurus Labs, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.1040 today, underscoring a notable phase of momentum in its stock performance. This milestone reflects the company’s sustained upward trajectory amid a broadly positive market environment.

Laurus Labs Hits New 52-Week High of Rs.1040 Marking Significant Milestone

2025-12-01 11:27:12

Laurus Labs, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high today, touching Rs.1040. This milestone reflects the stock’s sustained momentum and strong performance over the past year, significantly outpacing broader market indices.

Laurus Labs Hits New 52-Week High of Rs.1040 Marking Significant Milestone

2025-12-01 11:27:09

Laurus Labs has reached a new 52-week high, touching Rs.1040 today, underscoring a notable milestone in its market performance within the Pharmaceuticals & Biotechnology sector. This achievement reflects sustained momentum supported by strong financial metrics and positive quarterly results.

Laurus Labs Hits New 52-Week High of Rs.1040 Marking Strong Market Momentum

2025-12-01 11:27:09

Laurus Labs, a prominent player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.1040 today, underscoring a significant milestone in its market performance. This achievement reflects sustained momentum supported by robust financial metrics and favourable market conditions.

Laurus Labs Stock Hits All-Time High at Rs.1036 Amid Strong Performance

2025-12-01 09:33:06

Laurus Labs has reached a significant milestone by hitting a new 52-week high of Rs.1036, marking an all-time peak for the pharmaceutical and biotechnology company. This achievement reflects a sustained period of robust performance across multiple financial metrics and market indicators.

Laurus Labs Sees Notable Surge in Open Interest Amid Rising Market Momentum

2025-11-27 15:00:17

Laurus Labs, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a significant rise in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning. This development coincides with the stock trading near its 52-week high and outpacing sector performance, reflecting a dynamic phase for the company’s shares.

Laurus Labs Sees Notable Surge in Open Interest Amid Rising Market Momentum

2025-11-27 14:00:18

Laurus Labs, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning. This development coincides with the stock trading near its 52-week high and outpacing sector performance, reflecting growing investor focus on the company’s prospects.

View All News